--- title: "AVITA Medical (RCEL) stock: news and investor profile" url: "https://aibio.space/companies/avita-medical/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "AVITA Medical, Inc. (NASDAQ: RCEL), United States. Listing facts, related biotech companies and news on aibio.space." --- RCEL AVITA Medical, Inc. NASDAQ · United States # AVITA Medical (RCEL) news AVITA Medical, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker RCEL, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest AVITA Medical news We have not published a story on AVITA Medical yet. When there is news, it will appear here. ## AVITA Medical at a glance - **Ticker**: RCEL - **Listing**: NASDAQ - **Country**: United States - **Cash, Jun 30, 2026**: $11.1 million ### Related companies - [Synergy CHC](https://aibio.space/companies/synergy-chc/) OTC: SNYRQ - [ESCALON MEDICAL CORP](https://aibio.space/companies/escalon-medical/) OTC: ESMC - [ESTABLISHMENT LABS HOLDINGS INC.](https://aibio.space/companies/establishment-labs/) NASDAQ: ESTA - [ENCISION INC](https://aibio.space/companies/encision/) OTC: ECIA - [RAPID MICRO BIOSYSTEMS, INC.](https://aibio.space/companies/rapid-micro-biosystems/) NASDAQ: RPID - [Cytosorbents](https://aibio.space/companies/cytosorbents/) NASDAQ: CTSO - [Devonian Health Group](https://aibio.space/companies/devonian-health-dvhgf/) OTC: DVHGF - [ZIMMER BIOMET HOLDINGS, INC.](https://aibio.space/companies/zimmer-biomet/) NYSE: ZBH ### Also on NASDAQ - [YD Bio](https://aibio.space/companies/yd-bio/) YDES - [Vericel](https://aibio.space/companies/vericel/) VCEL - [Greenwich LifeSciences](https://aibio.space/companies/greenwich-lifesciences/) GLSI - [China SXT Pharmaceuticals](https://aibio.space/companies/china-sxt-pharmaceuticals/) SXTC - [GeoVax Labs](https://aibio.space/companies/geovax-labs/) GOVX - [Compugen](https://aibio.space/companies/compugen/) CGEN ## AVITA Medical annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$71.6 million](https://www.sec.gov/Archives/edgar/data/1762303/000119312526049031/) | [$64.3 million](https://www.sec.gov/Archives/edgar/data/1762303/000119312526049031/) | | Research and development | [$20.8 million](https://www.sec.gov/Archives/edgar/data/1762303/000119312526049031/) | [$20.4 million](https://www.sec.gov/Archives/edgar/data/1762303/000119312526049031/) | | Net income (loss) | [-$48.6 million](https://www.sec.gov/Archives/edgar/data/1762303/000119312526049031/) | [-$61.8 million](https://www.sec.gov/Archives/edgar/data/1762303/000119312526049031/) | | Cash from operations | [-$31.2 million](https://www.sec.gov/Archives/edgar/data/1762303/000119312526049031/) | [-$48.9 million](https://www.sec.gov/Archives/edgar/data/1762303/000119312526049031/) | | Cash and equivalents | [$10.2 million](https://www.sec.gov/Archives/edgar/data/1762303/000119312526338101/) | [$14.1 million](https://www.sec.gov/Archives/edgar/data/1762303/000119312526049031/) | | Short-term investments | [$7.9 million](https://www.sec.gov/Archives/edgar/data/1762303/000119312526338101/) | [$21.8 million](https://www.sec.gov/Archives/edgar/data/1762303/000119312526049031/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $9.1 million, plus short-term investments of $2.0 million, $11.1 million in all. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about AVITA Medical What is the ticker symbol of AVITA Medical? AVITA Medical, Inc. trades under the ticker RCEL on NASDAQ. Where is AVITA Medical listed? AVITA Medical, Inc. is listed on NASDAQ. Which country or territory is AVITA Medical listed under? Our directory records AVITA Medical, Inc. under United States. Does aibio.space cover AVITA Medical? aibio.space lists AVITA Medical, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. What was AVITA Medical's revenue last year? $71.6 million for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is AVITA Medical profitable? AVITA Medical, Inc. reported a net loss of $48.6 million for the fiscal year ended Dec 31, 2025, and used $31.2 million of cash in operations, per its annual report to the SEC. How much does AVITA Medical spend on research and development? $20.8 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does AVITA Medical have? $11.1 million in cash and short-term investments at Jun 30, 2026, per its 10-Q. ## Investor discussion: AVITA Medical Members talk about AVITA Medical (RCEL). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at AVITA Medical, newest first. Each line links the filing it comes from. 1. 2026-06-08 Financings Filed a final prospectus for a securities offering. SEC Form 424B5. [Source](https://www.sec.gov/Archives/edgar/data/1762303/000176230326000010/424b5_-_perceptive_warra.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:RCEL on TradingView](https://www.tradingview.com/symbols/NASDAQ-RCEL/). ## Listing details AVITA Medical, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker RCEL, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: AVITA Medical, Inc. - **Ticker**: RCEL - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/avita-medical/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "AVITA Medical (RCEL) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/avita-medical/